Studii clinice

Sindrom Post COVID-19

Referințe și publicații relevante despre rolul studiat al HBOT în sindromul post-COVID-19.

HBOT, neuroplasticitate și ameliorarea simptomelor Long COVID

Un studiu recent efectuat la Centrul de Cercetare si Medicina Hiperbară Sagol, din Israel, demonstrează că terapia cu oxigen hiperbaric (HBOT) poate induce neuroplasticitatea și poate îmbunătăți semnificativ simptomele cognitive, psihiatrice, de oboseală, somn și durere ale pacienților care suferă de sindromul post-COVID-19.

Studiile arata ca prin creșterea perfuziei cerebrale și activarea neuroplasticității în regiunile cerebrale cu roluri cognitive și/sau emoționale, se pot îmbunătăți simptomele post-COVID-19. Beneficiile se manifestă la nivelurile: cognitiv, psihic, rezistenței la efort, calității somnului și algiei.

Bibliografie

Publicații și referințe

Yuxin Li, Jingnan Lin, Jiazhu Gao, Lijuan Tang

Efficacy and safety of hyperbaric oxygen therapy for long COVID: a protocol for systematic review and meta-analysis

BMJ Open 2024;14(5); DOI:10.1136/bmjopen-2024-083868; License CC BY-NC 4.0

Pingzhi Wang, Zhengtao Wang, Junyan Zhang, Caiqin Lan, Yani Zhao, Xiaoqing Chen, Yu Li, Qi Mei, Huijing Feng, Shuang Wei, Zhifeng Xue, Fang Gao, Xiaolei Liu, Ying Liang

Effect of Hyperbaric Oxygen Therapy on Patients with SARS-CoV-2 Infection: A Retrospective Cohort Study

PMID: 39600716; PMCID: PMC11590646; DOI: 10.2147/JMDH.S486170

Amir Hadanny, Shachar Finci, Merav Catalogna, Ramzia Abu Hamed, Calanit Korin, Levi Gabriella, Katia Adler-Vallach, Natalia Tarasula, Mahgna Hamad, Zemer Wang, Erez Lang, Yonatan Zemel, Yair Bechor, Noami Rahimi-Levene, Yonatan Shapira, Oleg Gorelik, Irma Tzur, Eduard Ilgiyaev, Avi Mizrachi, Eli Shiloah, Yasmin Maor, Osnat Lev-Zion Korach, Shai Efrati

Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial

9 Apr 2021

N.M. Allam, H.M. Eladl, M.M. Eid

Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review

2022; 26: 5618-5623

Anders Kjellberg, Adrian Hassler, Emil Boström, Sara El Gharbi, Sarah Al-Ezerjawi, Jan Kowalski, Kenny A. Rodriguez-Wallberg, Judith Bruchfeld, Marcus Ståhlberg, Malin Nygren-Bonnier, Michael Runold & Peter Lindholm

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial

BMC Infectious Diseases volume 23, Article number: 33 (2023)

Tim Robbins, Michael Gonevski, Cain Clark, Sudhanshu Baitule, Kavi Sharma, Angel Magar, Kiran Patel, Sailesh Sankar, Ioannis Kyrou, Asad Ali, Harpal S. Randeva

Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention

Clin Med (Lond). 2021 Nov; 21(6): e629–e632; DOI: 10.7861/clinmed.2021-0462; PMCID: PMC8806311; PMID: 34862223

Anders Kjellberg, Lina Abdel-Halim, Adrian Hassler, Sara El Gharbi, Sarah Al-Ezerjawi, Emil Boström, Carl Johan Sundberg, John Pernow, Koshiar Medson, Jan H Kowalski, Kenny A Rodriguez-Wallberg, Xiaowei Zheng, Sergiu Catrina, Michael Runold, Marcus Ståhlberg, Judith Bruchfeld, Malin Nygren-Bonnier, Peter Lindholm

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebocontrolled, double-blind, phase II clinical trial

DOI:10.1136/bmjopen-2022-061870

Anders Kjellberg, Johan Douglas, Adrian Hassler, Sarah Al-Ezerjawi, Emil Boström, Lina Abdel-Halim, Lovisa Liwenborg, Eric Hetting, Anna-Dora Jonasdottir-Njåstad, Jan Kowalski, Sergiu-Bogdan Catrina, Kenny Rodriguez-Wallberg, Peter Lindholm

COVID-19 induced acute respiratory distress syndrome treated with Hyperbaric Oxygen: Interim safety report from a multicenter, randomised, open-label phase II clinical trial (COVID-19-HBO)

DOI:10.21203/rs.3.rs-1494203/v1

Thiruppathy Palaniappan, Asif Shaikh, Navamani Kirthika

Effective Outcome of HBOT as an Adjuvant Therapy in Patients Diagnosed with COVID-19 in a Tertiary Care Hospital – A Preliminary Study

DOI:10.2478/jccm-2022-0008

Sead Žiga, Dejan Andrić, Sanja Jurić Banai, Kristina Franjić

The role of hyperbaric oxygenotherapy (HBOT) in the treatment of COVID-19 patients

DOI:10.26800/LV-143-11-12-9

Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Mohammad Mehrtak, Amirali Karimi, Tayebeh Noori, Pegah Mirzapour, Alireza Shojaei, Mehrzad MohsseniPour, Seyed Peyman Mirghaderi, Sanam Alilou, Parnian Shobeiri, Hadiseh Azadi Cheshmekabodi, Esmaeil Mehraeen & Omid Dadras

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review

European Journal of Medical Research volume 26, Article number: 96 (2021)

Chih-Cheng Lai, Chi-Kuei Hsu, Muh-Yong Yen, Ping-Ing Lee, Wen-Chien Ko, Po-Ren Hsueh

Long COVID: An inevitable sequela of SARS-CoV-2 infection

https://doi.org/10.1016/j.jmii.2022.10.003

Diana Kitala, Wojciech Łabuś, Jerzy Kozielski, Przemysław Strzelec, Mariusz Nowak, Grzegorz Knefel, Piotr Dyjas, Krzysztof Materniak, Jolanta Kosmala, Jolanta Pająk, Jolanta Czop, Barbara Janda-Kalus, Barbara Marona, Anna Nowak-Wróżyna, Marcin Gierek, Jan Szczegielniak and Marek Kucharzewski

Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome

J. Clin. Med. 2023, 12(1), 308; https://doi.org/10.3390/jcm12010308

Jacek Siewiera, Klaudia Brodaczewska, Natalia Jermakow, Arkadiusz Lubas, Krzysztof Kłos, Aleksandra Majewska, Jacek Kot

Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial

J. Clin. Med. 2023, 12(1), 8; https://doi.org/10.3390/jcm12010008

Aisha M. Bhaiyat, Efrat Sasson, Zemer Wang, Sherif Khairy, Mouzayan Ginzarly, Umair Qureshi, Moin Fikree & Shai Efrati

Hyperbaric oxygen treatment for long coronavirus disease-19: a case report

Journal of Medical Case Reports volume 16, Article number: 80 (2022)

Shin Jie Yong, Shiliang Liu

Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies

Medical Virology, 9 December 2021

Merav Catalogna, Efrat Sasson, Amir Hadanny, Yoav Parag, Shani Zilberman-Itskovich, Shai Efrati

Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trial

NeuroImage: Clinical, Volume 36, 2022, 103218

Chia Siang Kow, Dinesh Sangarran Ramachandram & Syed Shahzad Hasan

Hyperbaric oxygen therapy to reverse post-COVID cognitive impairment

Neurol Sci 43, 6185–6186 (2022)

José Alfredo Gonzalez‑Ramirez, Julio C. Ramírez‑Nava, Sonia Gonzalez‑Lopez, Bettina Sommer, Héctor Solís‑Chagoyán, Luis M. Montaño, Bianca S. Romero‑Martínez, Edgar Flores‑Soto

Hyperbaric oxygen therapy in overweight and obese patients with COVID‑19

Published online on: October 12, 2021; https://doi.org/10.3892/wasj.2021.132

Shani Zilberman-Itskovich, Merav Catalogna, Efrat Sasson, Karin Elman-Shina, Amir Hadanny, Erez Lang, Shachar Finci, Nir Polak, Gregory Fishlev, Calanit Korin, Ran Shorer, Yoav Parag, Marina Sova & Shai Efrati

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial

Scientific Reports volume 12, Article number: 11252 (2022)

Guillermo A. Keller, Ivana Colaianni, Javier Coria, Guillermo Di Girolamo, Silvia Miranda

Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure

Published: February 14, 2023; https://doi.org/10.1016/j.rmed.2023.107155

Marina Leitman, Shmuel Fuchs, Vladimir Tyomkin, Amir Hadanny, Shani Zilberman-Itskovich, Shai Efrati

The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial

Scientific Reports volume 13, Article number: 9473 (2023); https://doi.org/10.1038/s41598-023-36570-x

Alan A. Katz, Sandra Wainwright, Matthew P. Kelly, Pradeep Albert, Rosemary Byrne

Doriți să continuați explorarea studiilor?

Puteți reveni la pagina principală de studii clinice sau puteți lua legătura cu clinica prin pagina de contact.

Toate studiile Pagina de contact

Sindrom Post COVID-19

HBOT, neuroplasticitate și ameliorarea simptomelor Long COVID

Publicații și referințe

Efficacy and safety of hyperbaric oxygen therapy for long COVID: a protocol for systematic review and meta-analysis

Effect of Hyperbaric Oxygen Therapy on Patients with SARS-CoV-2 Infection: A Retrospective Cohort Study

Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial

Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial

Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebocontrolled, double-blind, phase II clinical trial

COVID-19 induced acute respiratory distress syndrome treated with Hyperbaric Oxygen: Interim safety report from a multicenter, randomised, open-label phase II clinical trial (COVID-19-HBO)

Effective Outcome of HBOT as an Adjuvant Therapy in Patients Diagnosed with COVID-19 in a Tertiary Care Hospital – A Preliminary Study

The role of hyperbaric oxygenotherapy (HBOT) in the treatment of COVID-19 patients

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review

Long COVID: An inevitable sequela of SARS-CoV-2 infection

Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome

Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial

Hyperbaric oxygen treatment for long coronavirus disease-19: a case report

Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies

Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trial

Hyperbaric oxygen therapy to reverse post-COVID cognitive impairment

Hyperbaric oxygen therapy in overweight and obese patients with COVID‑19

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial

Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure

The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial

Hyperbaric oxygen effectively addresses the pathophysiology of long COVID: clinical review

Bayesian Modeling of the Impact of HBOT on the Reduction in Cytokine Storms

Effects of Hyperbaric Oxygen Therapy on Long COVID: A Systematic Review

Doriți să continuați explorarea studiilor?